JP2016519109A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519109A5
JP2016519109A5 JP2016509072A JP2016509072A JP2016519109A5 JP 2016519109 A5 JP2016519109 A5 JP 2016519109A5 JP 2016509072 A JP2016509072 A JP 2016509072A JP 2016509072 A JP2016509072 A JP 2016509072A JP 2016519109 A5 JP2016519109 A5 JP 2016519109A5
Authority
JP
Japan
Prior art keywords
composition
composition according
patient
group
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016509072A
Other languages
English (en)
Japanese (ja)
Other versions
JP6405365B2 (ja
JP2016519109A (ja
Filing date
Publication date
Priority claimed from PCT/US2013/072884 external-priority patent/WO2014089088A1/en
Application filed filed Critical
Priority claimed from PCT/US2014/034392 external-priority patent/WO2014172474A2/en
Publication of JP2016519109A publication Critical patent/JP2016519109A/ja
Publication of JP2016519109A5 publication Critical patent/JP2016519109A5/ja
Application granted granted Critical
Publication of JP6405365B2 publication Critical patent/JP6405365B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016509072A 2013-04-16 2014-04-16 ペプチド化合物及びその製造方法及びその使用 Active JP6405365B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361812584P 2013-04-16 2013-04-16
US61/812,584 2013-04-16
US201361813527P 2013-04-18 2013-04-18
US61/813,527 2013-04-18
PCT/US2013/072884 WO2014089088A1 (en) 2012-12-03 2013-12-03 Peptide compounds and methods of production and use thereof
USPCT/US2013/072884 2013-12-03
PCT/US2014/034392 WO2014172474A2 (en) 2013-04-16 2014-04-16 Peptide compounds and methods of production and use thereof

Publications (3)

Publication Number Publication Date
JP2016519109A JP2016519109A (ja) 2016-06-30
JP2016519109A5 true JP2016519109A5 (cg-RX-API-DMAC7.html) 2017-06-15
JP6405365B2 JP6405365B2 (ja) 2018-10-17

Family

ID=51731978

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016509072A Active JP6405365B2 (ja) 2013-04-16 2014-04-16 ペプチド化合物及びその製造方法及びその使用

Country Status (7)

Country Link
US (3) US9624283B2 (cg-RX-API-DMAC7.html)
EP (1) EP2986309B1 (cg-RX-API-DMAC7.html)
JP (1) JP6405365B2 (cg-RX-API-DMAC7.html)
AU (1) AU2014254016B2 (cg-RX-API-DMAC7.html)
CA (1) CA2908693C (cg-RX-API-DMAC7.html)
DK (1) DK2986309T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014172474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3802568A4 (en) 2018-06-08 2022-07-13 The Board of Regents of the University of Oklahoma PEPTIDE THERAPEUTICS USED TO TREAT ALZHEIMER'S DISEASE AND RELATED DISEASES
JP2025016812A (ja) * 2021-12-16 2025-02-05 レグセル株式会社 免疫系の異常に関連する疾患、障害または症状を処置するための医薬組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6107460A (en) * 1999-03-01 2000-08-22 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use thereof
US8450071B2 (en) 2002-03-08 2013-05-28 The Board Of Regents Of The University Of Oklahoma Biomarker and method for detecting a chronic inflammatory-associated disease
AU2003220034A1 (en) 2002-03-08 2003-09-22 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
US7354900B2 (en) * 2002-05-03 2008-04-08 The Board Of Regents Of The University Of Oklahoma Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides
CN101027318B (zh) 2004-07-19 2016-05-25 比奥孔有限公司 胰岛素-低聚物共轭物,制剂及其用途
CN101300022A (zh) * 2005-08-01 2008-11-05 俄克拉荷马州大学评议会 抗真菌肽和其使用方法
US9399675B2 (en) 2007-02-28 2016-07-26 The Board Of Regents Of The University Of Oklahoma Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
GB0817121D0 (en) * 2008-09-18 2008-10-29 Univ St Andrews Anti-fungal therapy
WO2011103567A2 (en) 2010-02-22 2011-08-25 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Peptides and methods for inducing cell death
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9096679B2 (en) 2012-12-03 2015-08-04 The Board Of Regents Of The University Of Oklahoma Peptide compounds and methods of production and use thereof
US9603896B2 (en) 2012-12-03 2017-03-28 The Board Of Regents Of The University Of Oklahoma Peptide compounds and methods of production and use thereof

Similar Documents

Publication Publication Date Title
Bertesteanu et al. Polymicrobial wound infections: pathophysiology and current therapeutic approaches
JP6069396B2 (ja) 慢性の創傷を治療するための装置、及び、患者ケアキット
JP2015504921A5 (cg-RX-API-DMAC7.html)
SA520411571B1 (ar) مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية
RU2014134720A (ru) Противомикробные композиции, содержащие dgla, 15-онера и/или 15-hetre, и способы их применения
NZ713615A (en) Methods for treating bacterial infections
JP2017519035A (ja) 抗微生物性−抗バイオフィルム性組成物及び該組成物のパーソナルケア製品のための使用
JP2012522037A5 (cg-RX-API-DMAC7.html)
JP2012517420A5 (cg-RX-API-DMAC7.html)
JP2007500697A5 (cg-RX-API-DMAC7.html)
US9480669B2 (en) Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
JP2015512403A5 (cg-RX-API-DMAC7.html)
RU2017102306A (ru) Лизины ацинетобактеров
Gunjan et al. A comparative study of the effect of different topical agents on burn wound infections
EP2849777A1 (en) Use of seaprose to remove bacterial biofilm
ES2955834T3 (es) Variantes de plantaricina nc8alphabeta
US9549904B2 (en) Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
WO2016105510A3 (en) Methods and compositions for growth, storage, and use of bacterial preparations for wound and surface treatments
MX2015015176A (es) Composiciones antimicrobianas y metodos para su produccion.
WO2020201833A8 (en) Gepotidacin for use in the treatment of bacterial urinary tract infections
CR20230510A (es) Compuestos de lactivicina, su preparación y uso como agentes antibacterianos
JP2018530618A (ja) オキシドレダクターゼ酵素を含む組成物及びその抗菌的使用
PH12021550474A1 (en) Tetracycline complexes with sustained activity
US20230017920A1 (en) Shelf-stable hypochlorous acid
JP2014503469A5 (cg-RX-API-DMAC7.html)